Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study

Figure 2

Overall use of antiemetic medications in 343 women hospitalized for hyperemesis gravidarum illustrated by colors representing the stepwise treatment pathway defined in the national guidelines issued by the Norwegian Society for Gynecology and Obstetrics (NGF) in 2014: green = 1st line, yellow = 2nd line, orange = 3rd line, red = 4th line. ^aDopamine antagonists including metoclopramide. ^bn = 11 women of the n = 17 starting on dopamine antagonist also received ondansetron.